COMPOSITIONS AND METHODS FOR IMPROVING EYE FUNCTION

    公开(公告)号:US20240307481A1

    公开(公告)日:2024-09-19

    申请号:US18606224

    申请日:2024-03-15

    摘要: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, the disclosure, in one aspect, relates to unit dose compositions comprising (a) N-acetyl carnosine or a pharmaceutically acceptable salt thereof; (b) S-acetyl glutathione or a pharmaceutically acceptable salt thereof; (c) pterostilbene or a pharmaceutically acceptable salt thereof; (d) N-acetyl cysteine or a pharmaceutically acceptable salt thereof; (e) lutein or a pharmaceutically acceptable salt thereof; (f) taurine or a pharmaceutically acceptable salt thereof; (g) thiamine or a pharmaceutically acceptable salt thereof; (h) lycopene or a pharmaceutically acceptable salt thereof; and (i) zeaxanthin or a pharmaceutically acceptable salt thereof. In one aspect, the unit dose compositions improve eye function in a subject. In another aspect, the unit dose compositions treat or prevent eye disease is a subject.